RTW Biotech Growth Fund and RTW Investments, LP

Issuing agencies

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 197 (Wednesday, October 14, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 197 (Wednesday, October 14, 2026)]
[Notices]
[Pages 65275-65276]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-20936]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Investment Company Act Release No. 36357; File No. 812-16081]


RTW Biotech Growth Fund and RTW Investments, LP

October 8, 2026.
AGENCY: Securities and Exchange Commission (``Commission'' or ``SEC'').

ACTION: Notice.

-----------------------------------------------------------------------

    Notice of an application under section 6(c) of the Investment 
Company Act of 1940 (the ``Act'') for an exemption from sections 
18(a)(2), 18(c) and 18(i) of the Act, under sections 6(c) and 23(c) of 
the Act for an exemption from rule 23c-3 under the Act, and for an 
order pursuant to section 17(d) of the Act and rule 17d-1 under the 
Act.

SUMMARY OF APPLICATION: Applicants request an order to permit certain 
registered closed-end investment companies to issue multiple classes of 
shares, to impose early withdrawal charges, and to impose asset-based 
distribution and/or service fees.

APPLICANTS: RTW Biotech Growth Fund and RTW Investments, LP.

FILING DATE: The application was filed on August 28, 2026.

HEARING OR NOTIFICATION OF HEARING: An order granting the requested 
relief will be issued unless the Commission orders a hearing. 
Interested persons may request a hearing on any application by emailing 
the SEC's Secretary at <a href="/cdn-cgi/l/email-protection#dd8eb8beafb8a9bcafa4aef092bbbbb4beb89daeb8bef3bab2ab"><span class="__cf_email__" data-cfemail="8eddebedfcebfaeffcf7fda3c1e8e8e7edebcefdebeda0e9e1f8">[email&#160;protected]</span></a> and serving the 
Applicants with a copy of the request by email, if an email address is 
listed for the relevant Applicant below or personally or by mail, if a 
physical address is listed for the relevant Applicant below. The email 
should include the file number referenced above. Hearing requests 
should be received by the Commission by 5:30 p.m., Eastern time on 
November 2, 2026, and should be accompanied by proof of service on 
Applicants, in the form of an affidavit or, for lawyers, a certificate 
of service. Pursuant to rule 0-5 under the Act, hearing requests should 
state the nature of the writer's interest, any facts bearing upon the 
desirability of a

[[Page 65276]]

hearing on the matter, the reason for the request, and the issues 
contested. Persons who wish to be notified of a hearing may request 
notification by emailing the Commission's Secretary at <a href="/cdn-cgi/l/email-protection#e0b3858392859481929993cdaf8686898385a0938583ce878f96"><span class="__cf_email__" data-cfemail="9ac9fff9e8ffeefbe8e3e9b7d5fcfcf3f9ffdae9fff9b4fdf5ec">[email&#160;protected]</span></a>.

ADDRESSES: The Commission: <a href="/cdn-cgi/l/email-protection#90c3f5f3e2f5e4f1e2e9e3bddff6f6f9f3f5d0e3f5f3bef7ffe6"><span class="__cf_email__" data-cfemail="81d2e4e2f3e4f5e0f3f8f2accee7e7e8e2e4c1f2e4e2afe6eef7">[email&#160;protected]</span></a>. Applicants: 
Darshan Patel RTW Biotech Growth Fund, c/o RTW Investments, LP, 
<a href="/cdn-cgi/l/email-protection#5034201022242736253e34237e333f3d"><span class="__cf_email__" data-cfemail="98fce8d8eaeceffeedf6fcebb6fbf7f5">[email&#160;protected]</span></a>, with copies to: Pamela Poland Chen, Esq. 
<a href="/cdn-cgi/l/email-protection#2a5a4b474f464b0449424f446a41435841464b444e04494547"><span class="__cf_email__" data-cfemail="e292838f878e83cc818a878ca2898b90898e838c86cc818d8f">[email&#160;protected]</span></a> and Jessica L. Patrick, Esq., 
<a href="/cdn-cgi/l/email-protection#bbd1dec8c8d2d8da95cbdacfc9d2d8d0fbd0d2c9d0d7dad5df95d8d4d6"><span class="__cf_email__" data-cfemail="4b212e383822282a653b2a3f392228200b20223920272a252f65282426">[email&#160;protected]</span></a>, respectively.

FOR FURTHER INFORMATION CONTACT: Rachel Loko, Senior Special Counsel, 
at (202) 551-6720 or <a href="/cdn-cgi/l/email-protection#50191d1f1313102335337e373f26"><span class="__cf_email__" data-cfemail="a7eeeae8e4e4e7d4c2c489c0c8d1">[email&#160;protected]</span></a> (Division of Investment Management, 
Chief Counsel's Office).

SUPPLEMENTARY INFORMATION: For Applicants' representations, legal 
analysis, and conditions, please refer to Applicants' application, 
dated August 28, 2026, which may be obtained via the Commission's 
website by searching for the file number at the top of this document, 
or for an Applicant using the Company name search field, on the SEC's 
EDGAR system. The SEC's EDGAR system may be searched at, <a href="https://www.sec.gov/search-filings">https://www.sec.gov/search-filings</a>.
    You may also call the SEC's Office of Investor Education and 
Assistance at (202) 551-8090.

    For the Commission, by the Division of Investment Management, 
under delegated authority.
Sherry R. Haywood,
Assistant Secretary.
[FR Doc. 2026-20936 Filed 10-13-26; 8:45 am]
BILLING CODE 8011-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>